IBDEI0NF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10425,0)
 ;;=H16.402^^74^679^7
 ;;^UTILITY(U,$J,358.3,10425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10425,1,3,0)
 ;;=3^Corneal Neovascularization,Left Eye
 ;;^UTILITY(U,$J,358.3,10425,1,4,0)
 ;;=4^H16.402
 ;;^UTILITY(U,$J,358.3,10425,2)
 ;;=^5004966
 ;;^UTILITY(U,$J,358.3,10426,0)
 ;;=H18.20^^74^679^8
 ;;^UTILITY(U,$J,358.3,10426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10426,1,3,0)
 ;;=3^Corneal Edema
 ;;^UTILITY(U,$J,358.3,10426,1,4,0)
 ;;=4^H18.20
 ;;^UTILITY(U,$J,358.3,10426,2)
 ;;=^5005035
 ;;^UTILITY(U,$J,358.3,10427,0)
 ;;=H18.231^^74^679^9
 ;;^UTILITY(U,$J,358.3,10427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10427,1,3,0)
 ;;=3^Corneal Edema,Right Eye,Secondary
 ;;^UTILITY(U,$J,358.3,10427,1,4,0)
 ;;=4^H18.231
 ;;^UTILITY(U,$J,358.3,10427,2)
 ;;=^5005044
 ;;^UTILITY(U,$J,358.3,10428,0)
 ;;=H18.232^^74^679^10
 ;;^UTILITY(U,$J,358.3,10428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10428,1,3,0)
 ;;=3^Corneal Edema,Left Eye,Secondary
 ;;^UTILITY(U,$J,358.3,10428,1,4,0)
 ;;=4^H18.232
 ;;^UTILITY(U,$J,358.3,10428,2)
 ;;=^5005045
 ;;^UTILITY(U,$J,358.3,10429,0)
 ;;=H18.11^^74^679^11
 ;;^UTILITY(U,$J,358.3,10429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10429,1,3,0)
 ;;=3^Bullous Keratopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,10429,1,4,0)
 ;;=4^H18.11
 ;;^UTILITY(U,$J,358.3,10429,2)
 ;;=^5005032
 ;;^UTILITY(U,$J,358.3,10430,0)
 ;;=H18.12^^74^679^12
 ;;^UTILITY(U,$J,358.3,10430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10430,1,3,0)
 ;;=3^Bullous Keratopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,10430,1,4,0)
 ;;=4^H18.12
 ;;^UTILITY(U,$J,358.3,10430,2)
 ;;=^5005033
 ;;^UTILITY(U,$J,358.3,10431,0)
 ;;=H18.51^^74^679^13
 ;;^UTILITY(U,$J,358.3,10431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10431,1,3,0)
 ;;=3^Endothelial Corneal Dystrophy
 ;;^UTILITY(U,$J,358.3,10431,1,4,0)
 ;;=4^H18.51
 ;;^UTILITY(U,$J,358.3,10431,2)
 ;;=^268988
 ;;^UTILITY(U,$J,358.3,10432,0)
 ;;=H18.50^^74^679^14
 ;;^UTILITY(U,$J,358.3,10432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10432,1,3,0)
 ;;=3^Hereditary Corneal Dystrophies
 ;;^UTILITY(U,$J,358.3,10432,1,4,0)
 ;;=4^H18.50
 ;;^UTILITY(U,$J,358.3,10432,2)
 ;;=^5005084
 ;;^UTILITY(U,$J,358.3,10433,0)
 ;;=H18.601^^74^679^15
 ;;^UTILITY(U,$J,358.3,10433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10433,1,3,0)
 ;;=3^Keratoconus,Right Eye
 ;;^UTILITY(U,$J,358.3,10433,1,4,0)
 ;;=4^H18.601
 ;;^UTILITY(U,$J,358.3,10433,2)
 ;;=^5005089
 ;;^UTILITY(U,$J,358.3,10434,0)
 ;;=H18.602^^74^679^16
 ;;^UTILITY(U,$J,358.3,10434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10434,1,3,0)
 ;;=3^Keratoconus,Left Eye
 ;;^UTILITY(U,$J,358.3,10434,1,4,0)
 ;;=4^H18.602
 ;;^UTILITY(U,$J,358.3,10434,2)
 ;;=^5005090
 ;;^UTILITY(U,$J,358.3,10435,0)
 ;;=H18.423^^74^679^17
 ;;^UTILITY(U,$J,358.3,10435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10435,1,3,0)
 ;;=3^Band Keratopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,10435,1,4,0)
 ;;=4^H18.423
 ;;^UTILITY(U,$J,358.3,10435,2)
 ;;=^5005068
 ;;^UTILITY(U,$J,358.3,10436,0)
 ;;=H16.213^^74^679^18
 ;;^UTILITY(U,$J,358.3,10436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10436,1,3,0)
 ;;=3^Exposure Keratoconjunctivitis,Bilateral
 ;;^UTILITY(U,$J,358.3,10436,1,4,0)
 ;;=4^H16.213
 ;;^UTILITY(U,$J,358.3,10436,2)
 ;;=^5004922
 ;;^UTILITY(U,$J,358.3,10437,0)
 ;;=H18.833^^74^679^19
 ;;^UTILITY(U,$J,358.3,10437,1,0)
 ;;=^358.31IA^4^2
